Pharmaceutical Formulation Production Capacity:

Equipped with three production lines capable of manufacturing various dosage forms, including tablets and ointments, with a planned annual capacity of 115 million tablets and 10 million ointments.

API Production Capacity:

Equipped with three production lines, with a planned capacity for APIs and key intermediates of approximately 5.8 tons.